Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antagonists of the cannabinoid receptor CB1 for use in the treatment of diseases associated with neuronal dendritic abnormalities

Antagonists of the cannabinoid receptor CB1 for use in the treatment of diseases associated with neuronal dendritic abnormalities

US Patent 9662320 · Granted May 30, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Peptide compounds for reducing side effects of CB1 receptor agonists2025